Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/923,326external-prioritypatent/US8202967B2/en
Application filed by Boehringer Ingelheim Vetmedica, Inc.filedCriticalBoehringer Ingelheim Vetmedica, Inc.
Publication of CY1113614T1publicationCriticalpatent/CY1113614T1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Η παρούσα εφεύρεση αφορά νέες πρωτεΐνες αιμασυσσωματίνης Η5, νουκλεϊνικά οξέα και φορείς που κωδικοποιούν αυτές καθώς επίσης εμβόλια που περιλαμβάνουν οποιαδήποτε από τέτοιες Η5 πρωτεΐνες, νουκλεϊνικά οξέα ή φορείς που κωδικοποιούν αυτές τις Η5 πρωτεΐνες. Επιπλέον, η παρούσα εφεύρεση επίσης αφορά στην ιατρική χρήση οιωνδήποτε τέτοιων συνθέσεων σε ανθρώπους και ζώα.The present invention relates to novel H5 hemagglutinin proteins, nucleic acids and vectors encoding them as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding these H5 proteins. In addition, the present invention also relates to the medical use of any such compositions in humans and animals.
CY20121100945T2006-10-272012-10-12
H5 Proteins, Nucleic Acid Molecules, and Bodies Coding These and Their Medical Use
CY1113614T1
(en)